<DOC>
	<DOCNO>NCT00334945</DOCNO>
	<brief_summary>The purpose study evaluate effect growth hormone treatment phosphorus level body . Phosphorus important mineral bone growth . It well know growth hormone treatment improve bone density bone mineral content . The amount phosphorus maintain kidney . Fibroblast Growth Factor 23 recently recognize help kidneys control phosphate level .</brief_summary>
	<brief_title>Evaluate Effect Growth Hormone ( GH ) Treatment Fibroblast Growth Factor 23 , Known Phosphaturic Agent</brief_title>
	<detailed_description>This study compare Fibroblast Growth Factor 23 level child without growth hormone deficiency . Children growth hormone deficiency level take start growth hormone replacement initiate .</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Twenty child significant short stature &lt; 3rd percentile , age 314 year , refer Children 's Hospital Alabama Normal healthy volunteer child 318 year normal stature Patients medication include GH Patients concomitant hormonal abnormality Patients disorder calcium phosphate metabolism Active neoplasm Closed epiphysis Known bone disorder</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Fibroblast Growth Factors</keyword>
	<keyword>Bone development</keyword>
</DOC>